Opinion: Evolving Engineering

Exploiting the unique properties of living systems makes synthetic biologists better engineers.

Written byGeorge M. Church
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

George Church with a tape for measuring his facial morphology for a research project PERSONAL GENOME PROJECT

After 10 years of tinkering with biological circuits, we need to explain—once again and clearly—the rationale for doing synthetic biology. Despite the musings of some, the field is not limited to toy projects. Metabolic engineers have clearly articulated their goals of manufacturing cheap alkane fuels and much-needed drugs, such as the antimalarial drug artemisinin.[1. D.K. Ro et al., "Production of the antimalarial drug precursor artemisinic acid in engineered yeast," Nature 440: 940-43, 2006.] (See “Tinkering with Life.”) But for building DNA nanostructures or whole bacterial genomes, the rationales have been less clear—initially confined to cartoonish shapes and watermark sequences, respectively. Recent advances, however—such as a DNA nanostructure that combines cell targeting, molecular logic, and cancer-fighting ability[2. S.M. Douglas et al., “A logic-gated DNA capsule for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies